NCT02304991
|
2014-12-01 |
FARE Peanut SLIT and Early Tolerance Induction
|
Phase 2
|
Recruiting
|
NCT02046434
|
2014-01-01 |
Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain
|
Phase 1
|
Active, Not Recruiting
|
NCT02110810
|
2014-01-01 |
Indomethacin Decreases Post-ERCP Pancreatitis
|
Phase 3
|
Completed
|
NCT02074007
|
2013-12-01 |
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
|
Phase 3
|
Terminated
|
NCT02044341
|
2013-12-01 |
Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media
|
Phase 3
|
Completed
|
NCT01687218
|
2013-06-01 |
Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
|
Phase 2
|
Recruiting
|
NCT01911299
|
2013-05-01 |
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
|
Phase 2
|
Completed
|
NCT01575418
|
2013-03-01 |
An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations
|
Phase 1
|
Completed
|
NCT01575405
|
2013-03-01 |
A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
|
Phase 1
|
Completed
|
NCT01779258
|
2013-02-01 |
Emollients in the Management of Atopic Dermatitis
|
Phase 3
|
Completed
|
NCT01474499
|
2011-09-01 |
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3
|
Completed
|
NCT01373242
|
2011-06-01 |
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
NCT01339936
|
2011-03-01 |
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
|
Phase 2/Phase 3
|
Completed
|
NCT01126606
|
2010-08-01 |
Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional
|
Phase 3
|
Completed
|
NCT01158365
|
2010-07-01 |
Dermacyd in Odor Reducing.
|
Phase 3
|
Completed
|
NCT01335386
|
2010-04-01 |
Investigation of KLYX in Patients With Constipation
|
Phase 2
|
Completed
|
NCT00987727
|
2009-11-01 |
Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye
|
Phase 4
|
Completed
|
NCT00938704
|
2009-06-01 |
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
|
Phase 4
|
Completed
|
NCT00829985
|
2009-01-01 |
Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)
|
Phase 1/Phase 2
|
Completed
|
NCT00846235
|
2008-12-01 |
Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis
|
Phase 4
|
Completed
|
NCT00754884
|
2008-10-01 |
Calcitonin in the Treatment of Fibromyalgia
|
Phase 4
|
Enrolling By Invitation
|
NCT00779792
|
2008-09-01 |
Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation
|
Phase 4
|
Active, Not Recruiting
|
NCT00691197
|
2008-03-01 |
Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear
|
Phase 2/Phase 3
|
Completed
|
NCT00619203
|
2008-03-01 |
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
|
Phase 3
|
Completed
|
NCT00580606
|
2007-12-01 |
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
|
Phase 1/Phase 2
|
Completed
|
NCT00761202
|
2007-08-01 |
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
|
Phase 4
|
Completed
|
NCT00434421
|
2007-02-01 |
Sublingual Cockroach Safety Study (SCSS)
|
Phase 1
|
Completed
|
NCT01412658
|
2006-11-01 |
Clinical Safety of a Novel Milk Protein Peptide
|
Phase 1
|
Completed
|
NCT00243711
|
2005-09-01 |
A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop
|
Phase 2/Phase 3
|
Completed
|
NCT00332618
|
2003-09-01 |
Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia
|
Phase 2
|
Completed
|
NCT00003667
|
1998-09-01 |
Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
|
Phase 2
|
Completed
|